ArticleDermatology online journal2026
Epithelioid angiosarcoma of the scalp: An advanced and rare presentation.
Article in Dermatology online journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epithelioid angiosarcoma (EA) is a rare, aggressive vascular malignancy that often presents with nonspecific cutaneous findings, leading to delayed diagnosis. We report the case of a 73-year-old man with a persistent, painful lesion on the vertex and parietal scalp that failed to respond to multiple courses of antibiotics and topical therapies for presumed infectious and inflammatory dermatoses. Examination revealed crusted erosions and plaques with a nodular component, initially mimicking chronic inflammatory skin disease or a potentially neoplastic entity. Histopathologic evaluation of a punch biopsy demonstrated sheets of atypical epithelioid cells with marked nuclear pleomorphism and frequent mitoses. Immunohistochemical staining confirmed endothelial origin with diffuse positivity for ERG and CD31, while excluding squamous, melanocytic, lymphoid, and epithelial neoplasms. These findings established the diagnosis of EA. The patient was referred for oncology evaluation and initiated on radiation therapy. Cutaneous EA most commonly affects elderly White men and arises on the scalp or face. Prognosis remains poor, with 5-year survival rates below 15% because of high recurrence and early metastatic potential. This case underscores the importance of maintaining a high index of suspicion for EA in nonhealing scalp lesions and highlights the central role of histopathology and immunohistochemistry in establishing the diagnosis.
Indexed as
Identifiers
42246329What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.